The excitotoxic hypothesis suggests that cere bral ischemic damage results in part from the accumula tion of the excitatory and potentially toxic neurotransmit ters glutamate and aspartate. Adenosine, which also in creases during cerebral ischemia, is proposed to inhibit neurotransmitter release. The purpose of this study was to determine if adenosine receptor blockade exacerbates the accumulation of glutamate and aspartate during cere bral ischemia. Microdialysis probes, implanted bilaterally in the caudate nucleus of halothane-anesthetized rats, were used to (1) assess changes in interstitial fluid (ISF) glutamate, aspartate, adenosine, and adenosine metabo lites; (2) measure local cerebral blood flow (H2 clear ance); and (3) deliver 8-(p-sulfophenyl)theophylline (SPT) , an adenosine receptor antagonist, locally to the brain. The probe on one side of the brain was perfused Transient cerebral ischemia often leads to severe neuronal damage and death. The pathophysiology of the ischemic brain has been proposed to involve the cumulative effects of many factors, including increased intracellular calcium and lactate (Hoss man et al. , 1977; Rehncrona et al. , 1981) , elevations in free fatty acids (Bazan, 1976; Weiloch and Seisjo, 1981), and the generation of oxygen free radicals (Flamm et al., 1978; Rehncrona et al., 1980) . Re cently, the role of excitatory amino acid neurotrans-Abbreviations used: ANOVA, analysis of variance; ISF, in terstitial fluid; NMDA, N-methyl-D-aspartate; OPA, o-phthaldi aldehyde; SPT, 8-(p-sulfophenyl)theophylline.
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The CNS depressant effects of adenosine are well established and are believed to be mediated through specific extracellular adenosine receptors. Two subtypes of extracellular adenosine receptors, Al and A2, have been identified on the basis of phar-macological activity and tissue distribution (Stone, 1991) . Adenosine AI receptors, which mediate in hibition of adenylate cyclase activity, are found on neurons and are presumably involved in the regula tion of excitatory amino acid release (Meldrum, 1990) . Adenosine A 2 receptors, which mediate stim ulation of adenylate cyclase activity, are predomi nantly on vascular smooth muscle cells and are in volved in the regulation of cerebral blood flow.
Adenosine and its analogs have been shown to inhibit the K + -evoked release of glutamate and as partate in rat brain slice preparations (Dolphin and Archer, 1983; Burke and Nadler, 1988) and cellular fractions (Terrian et aI., 1989) . This action was re versed by methylxanthines. Dunwiddie et ai. (1981) have demonstrated a rank order of potencies of xan thines in their ability to antagonize depressant elec trophysiological responses to adenosine. Further more, Dunwiddie and Hoffer (1980) have shown that enzymatic degradation of adenosine produces excitatory effects similar to those elicited by the ophylline. In vivo, adenosine receptor agonists have been shown to (1) elevate seizure threshold to chemoconvulsants (Turski et aI. , 1985; Franklin et aI., 1988) and (2) protect against ischemic neuronal death in regions of the brain which are particularly vulnerable to neurotransmitter "exci totoxins" (Evans et aI., 1987; Daval et aI., 1989; von Lubitz et aI., 1988; Bielenberg, 1989; Connick and Stone, 1989) .
It is well established that during ischemia ISF levels of adenosine accumulate as A TP is rapidly depleted (Berne et aI., 1974; Van Wylen et aI., 1986; Hillered et aI. , 1989; Sciotti et aI., 1990) . This sug gests that endogenous adenosine, acting as a neu romodulator, may effect central nervous system ex citability during cerebral ischemia. If endogenous adenosine is involved in neuromodulation via a re ceptor-mediated inhibition of neurotransmitter re lease, one would expect to observe an enhanced release of ISF glutamate and aspartate during cere bral ischemia with adenosine receptor blockade. We tested this hypothesis using the microdialysis technique to deliver 8-(p-sulfophenyl)theophylline (SPT), an adenosine receptor antagonist, locally to the brain during cerebral ischemia and reperfusion. In addition, microdialysis was used to simulta neously measure changes in cerebral blood flow (CBF) and ISF levels of glutamate, aspartate, aden osine, and adenosine metabolites.
METHODS

Animal preparation
All experiments were performed on 300--500-g adult male Wistar rats. Animals were anesthetized initially with sodium thiamylal (50 mg/kg), after which a tracheostomy was performed and the animals mechanically ventilated with a mixture of oxygen, nitrogen, and 1.5-2.0% halo thane. Core body temperature was monitored with a rec tal temperature probe and maintained with a heating pad between 37 and 38°C. The left femoral artery was cannu lated for the measurement of arterial blood pressure (Statham model P23Db pressure transducer, Gould 2400 recorder, Greenbelt MD, U.S.A.) and the withdrawal of arterial blood samples. The right femoral artery was can nulated for hemorrhage during cerebral ischemia. Both common carotid arteries were then exposed. Silk sutures were placed around each artery and passed through poly ethylene tubing to form snare ligatures.
In all animals, brain dialysate samples were collected bilaterally from the caudate nuclei. The details of the brain microdialysis technique as utilized by our labora tory have been published previously (Van Wylen et aI., 1986 . In preparation for implantation of the microdialysis probes in the brain, the animals were placed in a stereotaxic apparatus and the frontal and parietal bones of the skull were exposed. Burr holes were then made bilaterally 0.5 mm anterior and 2.5 mm lateral to the bregma and each of the microdialysis probes (Clirans TH 10; inner diameter 300 f.Lm, molecular weight cutoff 5,000 daltons) was lowered 8 mm below the dura such that a 5-mm length of dialysis fiber between the ends of the two silica tubes rested primarily in the caudate nucleus (Pel ligrino et aI., 1979) . Once implanted in the brain, microdi alysis probes were perfused with artificial cerebrospinal fluid (CSF) (NaCl 132.8 mM, NaHC03 24.6 mM, urea 6.7 mM, glucose 3.7 mM, KCI 3.0 mM, CaCI2 2.0 mM, and MgCI2 0.7 mM) at a constant flow of 0.5 f.LUmin (Carnegie Medicin AB model CMA100 microinjection pump, Lafay ette IN, U.S.A.).
CBF measurements
Local CBF was measured from the area surrounding the microdialysis probe by hydrogen clearance (Young, 1980) , using techniques previously described for local blood flow measurement in conjunction with brain mi crodialysis (Van Wylen et aI., 1988 . Hydrogen was introduced to the animal in the inspired air (7-10%) for approximately 2 min, after which the inspired hydrogen was turned off and the washout of hydrogen from the tissue monitored. Local CBF was calculated from the time required for the hydrogen levels to fall from 90 to 40% maximum using the formula: -In(40/90) CBF (ml 100 g-I min-I) =
x 100 time Protocol A 90-min period was allowed for recovery from mi crodialysis probe implantation, a time at which ISF pu rine levels have been shown to reach steady state levels (Van Wylen et aI., 1986) . Thereafter, dialysate samples were collected at 20-min intervals with the exception of ischemia and early reperfusion, during which time lO-min samples were collected. A baseline measurement of CBF and a collection of dialysate was made with both microdi alysis probes being perfused with CSF. A microdialysis probe on one side of the brain was then perfused with CSF containing 10 -3 M SPT (Research Biochemicals, Natick MA, U.S.A.), an adenosine receptor antagonist, for the remainder of the protocol, while the contralateral probe continued to be perfused with CSF alone. This dose of SPT was used because it has been shown to com pletely attenuate the CBF response to local infusion of 5' -N-ethylcarboximide adenosine, an adenosine receptor agonist (Van Wylen et aI., 1989) . CBF measurements were made and dialysate samples collected for 20 min of SPT infusion prior to cerebral ischemia. Immediately prior to the induction of ischemia, hydrogen was deliv ered to the animal. Reversible cerebral ischemia was then induced by bilateral carotid occlusion and arterial exsan guination to a blood pressure of 50 mm Hg. Hydrogen administration was then discontinued and a single CBF measurement was made during ischemia. Following 20 min of ischemia, blood pressure was restored by reinfu sion of the shed blood and the carotid snares were re moved. Dialysate samples were collected and CBF deter minations were made during a 60-min reperfusion period following ischemia.
Dialysate from six animals was used for the analysis of ISF glutamate and aspartate. Another six rats were sub jected to the same protocol for the determination of dial ysate adenosine and adenosine metabolites. In an addi tional four rats, dialysate samples collected were used for the determination of ISF amino acids as well as adeno sine, inosine, hypoxanthine, xanthine, and uric acid.
Analytical procedures
The concentrations of amino acids in the dialysate were determined by high performance liquid chromatography (HPLC) after precolumn derivatization with o-phthaldial de hyde (OPA, Pierce, Rockford IL, U.S.A.), as de scribed by Lindroth and Mopper (1979) . Briefly, 40 ILl of diluted sample were reacted with 20 ILl of OP A and in jected onto an HPLC system (Waters Division of Milli pore, Milford MA, U.S.A.). Amino acids were separated on a Resolve CI8 column (Waters) using a gradient elu tion profile (buffer A: 50 mM NaHP04, 50 mM NaOAC, pH 7.0, containing 2% methanol and 2% tetrohydrofuran; buffer B: 65% methanol).
Determination of dialysate adenosine, inosine, hypo xanthine, xanthine, and uric acid concentrations was per formed with reverse phase HPLC and ultraviolet detec tion at a wavelength of 254 nm. Separation of the com pounds of interest was achieved using a CI8 column (Supelco, Bellefonte PA, U.S.A.) and a 1% (pH 5.3) to 25% (pH 5.58) methanol in 100 mM KH2P04 gradient. Identification of nucleosides as well as amino acids was accomplished by comparing retention times and peak ar eas with those of external standards.
Statistical analysis
Mean values and standard errors of the means were calculated for all the data. Differences between mean val ues were determined using one of two types of statistical analysis: (1) paired t-test for comparisons of dialysate concentrations from the untreated side of the brain with those collected at the same time from the treated side; (2) analysis of variance (ANOV A) followed by Dunnett's test for comparisons of dialysate concentrations for a given side to baseline. A p < 0.05 was accepted as indication of a statistically significant difference.
RESULTS
The systemic cardiovascular parameters are shown in Table 1 . The local infusion of SPT did not affect arterial blood pressure, POz, PC0 2 , or pH. Arterial blood gas values did not change signifi cantly during the course of the protocol. However, mean arterial blood pressure tended to decline over time, and was significantly lower during the last reperfusion period.
Dialysate levels of measured purine metabolites and amino acids are presented in Figs. 1-7 . Baseline dialysate concentrations (fLM) on the untreated side were: glutamate 3.0 ± 0.4, aspartate 0.9 ± 0 . 3, adenosine 0. 6 ± 0.1, inosine 1. 2 ± 0.2, hypoxan thine 3.7 ± 0.5, xanthine 3.0 ± 0. 4, and uric acid 3.3 ± 0.5. On the side that was subsequently infused with SPT, the baseline dialysate levels were (fLM) glutamate 4. 2 ± 0.7, aspartate 1.0 ± 0.3, adenosine 0.5 ± 0.1, inosine 1.1 ± 0.2, hypoxanthine 4.1 ± 1.2, xanthine 2.9 ± 0. 4, and uric acid 2.7 ± 0.3 . The addition of 10 -3 M SPT to the dialysis probe prior to induction of ischemia did not significantly change dialysate levels of purine metabolites or amino ac ids.
On the untreated side of the brain, ischemia re sulted in an elevation of dialysate adenosine, ino sine, hypoxanthine, glutamate, and aspartate that was apparent in the first collection period. Dialy- 1-3) and then re turned toward basal levels during reperfusion. Al though dialysate levels of inosine, hypoxanthine, xanthine, and uric acid increased during ischemia, the highest levels were observed in the reperfusion period ( Figs. 4-7) .
A similar pattern of purine metabolites and amino acids during ischemia and reperfusion was observed on the side of locally infused SPT. However, dial ysate levels of the measured purine metabolites and amino acids were significantly higher in the pres-12 * o 1 0 20 30 40 50 60 Reperfusion TIME (minutes) ence of SPT. Glutamate levels on the side of locally infused SPT were increased II-fold over basal lev els and were 4-fold greater than dialysate levels ob served during the same ischemic time period on the untreated side of the brain (43.7 ± 7.4 vs. 10.8 ± 2.7 f-LM; Fig. 1 ). Dialysate aspartate was two times greater on the side of locally infused SPT during ischemia (5.8 ± 1.0 vs. 2.9 ± 0.9 f-LM; Fig. 2 ) and three times greater on the SPT -infused side during the first reperfusion period (7.6 ± 3.7 vs. 2.5 ± 0.5 f-LM; Fig. 2 ). Significant increases in dialysate aden osine and adenosine metabolites above the un treated side were also observed during ischemia and reperfusion. Adenosine levels observed during isch emia on the side of locally infused SPT were ap proximately 2-fold greater than levels on the un treated side (13.0 ± 2.0 vs. 6. 0 ± 2.5 fLM; Fig. 3 ). Figure 8 depicts local CBF responses to ischemia in the absence and presence of SPT. Although a 12% decrease in CBF was observed when SPT was added to the CSF perfusing the microdialysis probe, this difference was not significantly different when compared to baseline blood flow levels. CBF levels of approximately 12 ml 100 g -1 g min -1 were mea sured during 20 min of cerebral ischemia. An in crease in CBF was observed on both sides of the ISC 20 excitatory amino acid release from the caudate nu cleus of rats before, during, and after cerebral isch emia in the absence and presence of adenosine re ceptor blockade. The major finding of this study is that ISF levels of the excitatory amino acids gluta mate and aspartate were enhanced during ischemia and reperfusion in the presence of the adenosine receptor antagonist SPT. In addition, SPT adminis tration resulted in increased ischemia-induced re lease of adenosine and adenosine metabolites when compared to the untreated side of the brain.
The magnitude of changes in ISF amino acid con centrations during ischemia and reperfusion ob-
served in this study is in agreement with values es timated by other investigators using microdialysis (Benveniste et aI. , 1984; Hagberg et aI. , 1985; HiIl ered et aI., 1989; Shimada et aI., 1990) ; however, estimates of ISF amino acid concentrations ob tained with microdialysis are substantially higher than those reported by Phillis et ai. (1991) , as esti mated using the cortical cup technique. This differ ence between dialysate and cortical cup levels of amino acids is similar to the reported 8-1O-fold lower adenosine levels obtained using the cortical cup technique (Phillis et aI. , 1987) . These differ ences in estimated ISF metabolite levels have been attributed to the different technical approaches uti lized to sample cerebral ISF (Phillis, 1989; Van Wylen et ai. , 1991) . Many excitatory neurons of the mammalian cen tral nervous system use glutamate or aspartate as a neurotransmitter (Fornum, 1984) . Lucas and New house (1957) were the first to report the neurotoxic effects of elevated extracellular glutamate. The ex citotoxic hypothesis, as described by Rothman and Olney (1986) , has since been used to describe the neuronal damage resulting from cerebral ischemia! hypoxia as well as certain neurodegenerative dis ease states. The excitotoxic hypothesis suggests 
Reperfusion TIME (minutes) Burke and Nadler (1988) have demonstrated, in vitro, adenosine's ability to modulate neurotrans mitter release from the brain. Prestwich et aI. (1987) have also observed increases in glutamate release when exposing cerebellar granule cells to bath ap plications of the adenosine receptor antagonist 8-phenyltheophylline. This response was attenu ated by the adenosine Al agonist R( -)-phenyl isopropyl adenosine. Similar effects on glutamate release have been demonstrated in vitro by Dolphin and Archer (1983) using the adenosine agonist and antagonist 2-chloroadenosine and theophylline, re spectively.
Our data provide evidence that endogenous aden osine is involved in the modulation of excitatory amino acid release during cerebral ischemia. Local administration of SPT markedly potentiated the ischemia-induced release of neurotransmitters and resulted in a sustained elevation of ISF glutamate through 50 min of reperfusion. Our interpretation of this response is that SPT, by blocking presynaptic adenosine Al receptors, interferes with the adeno sine-mediated attenuation of neurotransmitter re lease that normally occurs during cerebral isch emia. Our data is consistent with the data of Andine et al. (1990) who, using microdialysis, have demon strated that augmentation of extracellular adenosine concentration with propentofylline (an adenosine uptake blocker) during ischemia is associated with an attenuation of extracellular glutamate levels. The benefit of increased adenosine during ischemia has been shown by Rudolphi et aI. (1987) and Dux et al. (1990) , who have demonstrated that administration of theophylline exacerbates ischemia-induced neu ronal damage. In addition, Dux et aI. have demon strated that treatment with propentofylline in creases the ischemia induced neuronal and vascular changes. Taken together, these studies provide strong evidence that endogenous adenosine exerts a neuroprotective effect during cerebral ischemia.
A greater increase in ISF purine metabolites was observed during ischemia and early reperfusion on the side of locally infused SPT. This greater in crease in adenosine and adenosine metabolites in the presence of adenosine receptor blockade may result from an increased metabolic activity of cells in response to elevations of excitatory neurotrans mitters. Hoehn and White (1990) have recently re ported increases in adenosine release from slices of rat parietal cortex following glutamate stimulation. Glutamate-evoked adenosine release was not de creased when ecto-5' -nucleotidase was inhibited, indicating that elevations in superfusate levels of adenosine were not derived from the extracellular metabolism of nucleotides. In addition, they have demonstrated that glutamate-stimulated increases in adenosine release are mediated through both NMDA and non-NMDA receptors. Thus, enhanced adenosine release during ischemia in the presence of SPT may be the consequence of increased ATP metabolism resulting from the cellular hyperactivity associated with overstimulation of glutamate recep tors. This interpretation is supported by the work of Hagberg et al. (1986) who demonstrated an attenu ation of purine metabolite release during ischemia in the presence of NMDA receptor blockade. They suggest that NMDA receptor antagonism prevents excitatory amino acids from activating receptors which enhance neuronal uptake of Na + and Ca 2 + , resulting in increased energy consumption. Although we believe that the results obtained with SPT are due to its blockade of adenosine re ceptors, there are other reported effects of meth ylxanthines. At high intracellular concentrations (10� 3 M or greater) methylxanthines increase the release of intracellular calcium (Blinks et aI., 1972) and increase cyclic AMP levels as a result of inhi bition of cyclic nucleotide phosphodiesterase (Sutherland and Rail, 1958) . Two aspects argue against an intracellular action of SPT in our studies. First, because SPT is a polar compound with lim ited ability to penetrate cell membranes, it is un likely that SPT reaches high enough intracellular concentrations to achieve these effects. Second, there were no changes in preischemia CBF or dial ysate metabolite levels on the SPT-treated side of the brain when compared to baseline. It should be noted that the concentration of SPT present in the CSF perfusing the dialysis probe (lO� 3 M) is not the concentration of the adenosine antagonist in the tis sue. The average concentration of SPT present in the tissue from which amino acids and purine me tabolites are being measured is likely to be substan tially less than the artificial CSF concentration.
The vasodilator effects of adenosine have been well described (Berne et al. , 1974; Winn et al., 1981; Van Wylen et aI. , 1991) . However, despite the fact that SPT is a nonselective adenosine receptor an tagonist and, therefore, should have blocked aden osine A 2 receptors, we observed no significant dif ference in CBF between the two sides of the brain in response to local infusion of the receptor blocker. There are two possible explanations for this obser vation. First, ISF levels of glutamate and aspartate achieved with SPT infusion could be high enough to directly dilate cerebral resistance vessels. Busija and Leffler (1989) have demonstrated a dilator ef fect of topically applied amino acids on piglet pial arterioles. Alternatively, high levels of excitatory amino acids may increase local brain activity and thus, via adenosine-independent mechanisms, re sult in enhanced CBF as a consequence of tissue oxygen and energy supply/demand imbalances. In the latter scenario, SPT may be attenuating a po tentially greater hyperemic response to increased metabolic activity. Van Wylen and Moffe (1988) have reported a 236% increase in CBF induced by local infusion of the glutamate agonist kainic acid. This hyperemic response to kainic acid was atten uated but not eliminated in the presence of SPT.
In conclusion, ISF purine metabolites and excit atory amino acids are potentiated during cerebral ischemia in the presence of adenosine receptor blockade. The data presented support a role for adenosine in the inhibition of excitatory amino acid release during cerebral ischemia and suggest that adenosine may have a cerebroprotective action.
